Table.
Year | Population | Tested (n) |
Anti-hepatitis D virus positive |
Hepatitis D virus RNA positive* |
||||
---|---|---|---|---|---|---|---|---|
n (%) | 95% CI | n (%) | 95% CI | |||||
General populations | ||||||||
West Africa | ||||||||
Benin21 | 2011 | Pregnant women† | 44 | 5 (11%) | 5–24 | ·· | ·· | |
Burkina Faso31 | 2015 | Blood donors | 177 | 6 (3%) | 1–7 | ·· | ·· | |
Burkina Faso18 | 2001 | Mothers | 40 | 1 (3%) | 0–14 | 0 (0) | 0–83 | |
The Gambia34 | 2013 | Community members† | 394 | 8 (2%) | 1–4 | ·· | ·· | |
The Gambia34 | 2013 | Blood donors | 292 | 1 (<1%) | 0–2 | ·· | ·· | |
Ghana33 | 2015 | Community members† | 107 | 9 (8%) | 4–15 | ·· | ·· | |
Ghana‡ | 2010 | Patients from HIV clinics | 222 | 5 (2%) | 1–5 | 2 (40%) | 12–77 | |
Guinea-Bissau23 | 2011 | Patients from HIV clinics | 72 | 18 (25%) | 16–36 | 4 (44%)§ | 19–73 | |
Mauritania25 | 2008 | Blood donors | 447 | 90 (20%) | 17–24 | 56 (62%) | 52–72 | |
Mauritania26 | 2008–09 | Pregnant women | 109 | 16 (15%) | 9–23 | 11 (69%) | 44–86 | |
Mauritania26 | 2008–09 | Medical outpatients¶ | 162 | 31 (19%) | 14–26 | 21 (68%) | 50–82 | |
Nigeria32 | 2014 | Medical outpatients¶ | 103 | 5 (5%) | 2–11 | ·· | ·· | |
Nigeria18 | 2004 | Patients from HIV clinics | 45 | 3 (7%) | 2–19 | 2 (67%) | 20–94 | |
Nigeria18 | 1998 | Patients from HIV clinics | 11 | 3 (27%) | 9–57 | 0 (0) | 0–62 | |
Senegal30 | 2003 | Blood donors | 175 | 5 (3%) | 1–7 | ·· | ·· | |
Senegal22 | 1998–2002 | Patients from HIV clinics | 61 | 2 (3%) | 0–12 | ·· | ·· | |
Central Africa | ||||||||
Cameroon42 | 2011 | National survey participants | 1627 | 225 (14%) | 12–15 | ·· | ·· | |
Cameroon36 | 2011 | Health-care workers† | 17 | 6 (35%) | 17–59 | ·· | ·· | |
Cameroon41 | 2010 | Patients from HIV clinics | 25 | 3 (12%) | 3–31 | 1 (33%) | 6–80 | |
Cameroon37 | 2007 | Pregnant women† | 259 | 19 (7%) | 5–11 | ·· | ·· | |
Gabon43 | 2015 | Community members†|| | 74 | 33 (45%) | 33–56 | ·· | ·· | |
Gabon39 | 2005 | Pregnant women | 109 | 17 (16%) | 10–24 | ·· | ·· | |
Gabon40 | 2008 | Community members†|| | 124 | 82 (66%) | 57–74 | ·· | ·· | |
East or southern Africa | ||||||||
Botswana44 | 2006–08 | Pregnant women | 9 | 0 (0) | 0–35 | ·· | ·· | |
Malawi‡ | 2007–09 | Patients from HIV clinics | 133 | 2 (2%) | 0–6 | 0 (0) | 0–71 | |
Mozambique45 | 2007 | Blood donors | 146 | 0 (0) | 0–3 | ·· | ·· | |
South Africa19 | 2008 | Pregnant women | 87 | 0 (0) | 0–5 | ·· | ·· | |
South Africa44 | 2008 | HIV-positive pregnant or postnatal women | 45 | 0 (0) | 0–9 | ·· | ·· | |
South Africa44 | 2004–10 | Pregnant women | 6 | 0 (0) | 0–44 | ·· | ·· | |
Tanzania46 | 2013–14 | Patients from HIV clinics† | 219 | 11 (5%) | 3–9 | 0 (0) | 0–30 | |
Liver disease populations | ||||||||
West Africa | ||||||||
Ghana20 | 2014 | Patients from hepatology clinics | 53 | 6 (11%) | 5–23 | ·· | ·· | |
Mauritania24 | 2009 | Patients from hepatology clinics | 296 | 98 (33%) | 28–39 | 61 (62%) | 52–71 | |
Nigeria28 | 2012 | Patients with HCC | 26 | 0 (0) | 0–15 | ·· | ·· | |
Nigeria29 | 2009–10 | Patients from hepatology clinics (15% had cirrhosis, 3% had HCC) | 245 | 5 (2%) | 1–5 | ·· | ·· | |
Nigeria47 | 2006 | Patients from hepatology clinics (22% had cirrhosis, 51% had HCC) | 96 | 12 (13%) | 1–21 | ·· | ·· | |
Nigeria18 | 2006 | Patients from hepatology clinics | 78 | 1 (1%) | 0–8 | 1 (100%) | 17–100 | |
Nigeria18 | 2003 | Patients from hepatology clinics | 44 | 3 (7%) | 2–19 | 0 (0) | 0–62 | |
Senegal30 | 2003 | Patients from hepatology clinics | 29 | 4 (14%) | 5–31 | ·· | ·· | |
Senegal27 | 1995 | Patients from hepatology clinics (39% had cirrhosis, 57% had HCC) | 54 | 13 (24%) | 15–37 | ·· | ·· | |
Central Africa | ||||||||
Cameroon38 | 2008–09 | Patients from hepatology clinics | 233 | 41 (18%) | 13–23 | 25 (61%) | 42–74 | |
Central African Republic18 | 2009 | Patients from hepatology clinics | 14 | 7 (50%) | 27–73 | 5 (71%) | 35–92 | |
Central African Republic35 | 2006–09 | Patients with HCC | 69 | 36 (52%) | 41–64 | ·· | ·· |
HCC=hepatocellular carcinoma.
Percentages are calculated in the group of patients who are anti-hepatitis D virus positive.
Study was done in a rural setting.
Data are from the present study.
Only nine of 18 samples were tested for hepatitis D virus RNA.
The study population was attendees at a general (non-hepatology) medical clinic without known liver disease.
Cluster-sampling community survey.